FDA Drug Recalls

Recalls / Class II

Class IID-1341-2019

Product

ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.

Affected lot / code info
Lots: 3171855, Exp. 12/19

Why it was recalled

Failed Dissolution Specifications: Out of specification result for dissolution.

Recalling firm

Firm
Chiesi USA, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
175 Regency Woods Place, Ste. 600, N/A, Cary, North Carolina 27518-8128

Distribution

Quantity
2118 bottles
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2019-05-31
FDA classified
2019-06-13
Posted by FDA
2019-06-19
Terminated
2021-03-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1341-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls